摘要
The authors conducted an animal model study and a phase 2 clinical trial to evaluate the safety and efficacy of focal therapy using micro-wave tissue coagulation(MTC)to treat prostate cancer.[1]The results indicated that focal therapy using microwave ablation is relatively safe and may be an option for lesion-targeted therapy for prostate cancer.
